The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
Global news & analysis，推荐阅读爱思助手下载最新版本获取更多信息
。业内人士推荐雷电模拟器官方版本下载作为进阶阅读
Signatories AdGuard adguard.com🇨🇾
https://feedx.site，推荐阅读51吃瓜获取更多信息